AccelBio participates in BioEurope, showcasing innovations and cultivating collaborations

AccelBio participated in BioEurope event in Munich from November 6th to 8th, actively advancing the frontiers of biotech. With a commitment to advancing the boundaries of biotech, AccelBio strategically utilized the event to explore synergies with industry leaders, investors, and potential partners.

At the conference, AccelBio unveiled its cutting-edge Organoids platform, presenting a pivotal opportunity to forge partnerships that will expedite the development and commercialization of groundbreaking medicines.


Sign up with your email address to receive news and updates.

By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.